NAFLD: A multisystem disease

Armstrong, 2014, Extrahepatic complications of nonalcoholic fatty liver disease, Hepatology, 59, 1174, 10.1002/hep.26717

Masuoka, 2013, Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals, Ann N Y Acad Sci, 1281, 106, 10.1111/nyas.12016

Tsuneto, 2010, Fatty liver incidence and predictive variables, Hypertens Res, 33, 638, 10.1038/hr.2010.45

Browning, 2004, Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity, Hepatology, 40, 1387, 10.1002/hep.20466

Blachier, 2013, The burden of liver disease in Europe: a review of available epidemiological data, J Hepatol, 58, 593, 10.1016/j.jhep.2012.12.005

Musso, 2011, Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity, Ann Med, 43, 617, 10.3109/07853890.2010.518623

Musso, 2014, Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis, PLoS Med, 11, e1001680, 10.1371/journal.pmed.1001680

Musso, 2013, Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis, Obes Rev, 14, 417, 10.1111/obr.12020

Lee, 2014, Radiologic evaluation of nonalcoholic fatty liver disease, World J Gastroenterol, 20, 7392, 10.3748/wjg.v20.i23.7392

Holt, 2006, Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects, Diabetologia, 49, 141, 10.1007/s00125-005-0070-x

Sumida, 2014, Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, World J Gastroenterol, 20, 475, 10.3748/wjg.v20.i2.475

Hernaez, 2011, Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis, Hepatology, 54, 1082, 10.1002/hep.24452

Reeder, 2011, Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy, J Magn Reson Imaging, 34, 729, 10.1002/jmri.22580

Szczepaniak, 2005, Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population, Am J Physiol Endocrinol Metab, 288, E462, 10.1152/ajpendo.00064.2004

Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701

Whalley, 2007, Hepatology outpatient service provision in secondary care: a study of liver disease incidence and resource costs, Clin Med, 7, 119, 10.7861/clinmedicine.7-2-119

Romeo, 2008, Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease, Nat Genet, 40, 1461, 10.1038/ng.257

Anstee, 2013, Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis, Nat Rev Gastroenterol Hepatol, 10, 330, 10.1038/nrgastro.2013.41

Hyysalo, 2013, A population-based study on the prevalence of NASH using scores validated against liver histology, J Hepatol, 60, 839, 10.1016/j.jhep.2013.12.009

Hyysalo, 2014, Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity, Diabetes, 63, 312, 10.2337/db13-0774

Mashek, 2014, Serum TAG analysis differentiates between genetic and obesity-associated NAFLD, Diabetes, 63, 42, 10.2337/db13-1500

Yoon, 2014, Hepatic fibrosis: prospective comparison of MR elastography and US shear wave elastography for evaluation, Radiology, 7, 132000

Ekstedt, 2006, Long-term follow-up of patients with NAFLD and elevated liver enzymes, Hepatology, 44, 865, 10.1002/hep.21327

Ekstedt, 2014, Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33years of follow-up, Hepatology

Charlton, 2011, Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States, Gastroenterology, 141, 1249, 10.1053/j.gastro.2011.06.061

de Marco, 1999, Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study, Diabetes Care, 22, 756, 10.2337/diacare.22.5.756

Brunt, 2004, Nonalcoholic steatohepatitis, Semin Liver Dis, 24, 3, 10.1055/s-2004-823098

Ladep, 2014, Incidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations, World J Gastroenterol, 20, 1544, 10.3748/wjg.v20.i6.1544

Konfortion, 2014, Time and deprivation trends in incidence of primary liver cancer subtypes in England, J Eval Clin Pract, 20, 498, 10.1111/jep.12188

Ertle, 2011, Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis, Int J Cancer, 128, 2436, 10.1002/ijc.25797

Stickel, 2010, Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications, Gut, 59, 1303, 10.1136/gut.2009.199661

Starley, 2010, Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection, Hepatology, 51, 1820, 10.1002/hep.23594

Michelotti, 2013, NAFLD, NASH and liver cancer, Nat Rev Gastroenterol Hepatol, 10, 656, 10.1038/nrgastro.2013.183

Lee, 2014, Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance, Biochim Biophys Acta, 1842, 446, 10.1016/j.bbadis.2013.05.017

Beutler, 2009, TLRs and innate immunity, Blood, 113, 1399, 10.1182/blood-2008-07-019307

Yoshimoto, 2013, Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome, Nature, 499, 97, 10.1038/nature12347

Campbell, 2012, Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults, Diabetes Care, 35, 1835, 10.2337/dc12-0002

Zoppini, 2014, Mortality from chronic liver diseases in diabetes, Am J Gastroenterol, 109, 1020, 10.1038/ajg.2014.132

Maximos, 2014, The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease, Hepatology, 61, 153, 10.1002/hep.27395

Balkau, 2010, Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study, BMC Gastroenterol, 10, 56, 10.1186/1471-230X-10-56

Lee, 2004, Is serum gamma glutamyltransferase a marker of oxidative stress?, Free Radic Res, 38, 535, 10.1080/10715760410001694026

Yamada, 2010, Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup, J Gastroenterol Hepatol, 25, 352, 10.1111/j.1440-1746.2009.05998.x

Sung, 2012, Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes, Diabetes Care, 35, 717, 10.2337/dc11-1853

Shibata, 2007, Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men, Diabetes Care, 30, 2940, 10.2337/dc07-0792

Okamoto, 2003, The association of fatty liver and diabetes risk, J Epidemiol, 13, 15, 10.2188/jea.13.15

Kim, 2008, Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults, Diabet Med, 25, 476, 10.1111/j.1464-5491.2008.02410.x

Fan, 2007, Effects of nonalcoholic fatty liver disease on the development of metabolic disorders, J Gastroenterol Hepatol, 22, 1086, 10.1111/j.1440-1746.2006.04781.x

Bae, 2011, Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study, Diabetes Care, 34, 727, 10.2337/dc10-1991

Park, 2012, The clinical availability of non-alcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in korean men: 5-years’ prospective cohort study, Hepatology, 57, 1378, 10.1002/hep.26183

Kasturiratne, 2013, Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus, J Gastroenterol Hepatol, 28, 142, 10.1111/j.1440-1746.2012.07264.x

Chang, 2013, Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population, Am J Gastroenterol, 108, 1861, 10.1038/ajg.2013.349

Sung, 2013, Resolution of fatty liver and risk of incident diabetes, J Clin Endocrinol Metab, 98, 3637, 10.1210/jc.2013-1519

Morling, 2014, Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study, J Hepatol, 60, 384, 10.1016/j.jhep.2013.10.017

Byrne, 2013, Ectopic fat, insulin resistance and non-alcoholic fatty liver disease, Proc Nutr Soc, 72, 412, 10.1017/S0029665113001249

Kantartzis, 2010, The impact of liver fat vs. visceral fat in determining categories of prediabetes, Diabetologia, 53, 882, 10.1007/s00125-010-1663-6

Gao, 2011, Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity, J Biol Chem, 24, 22227, 10.1074/jbc.M111.228874

Samuel, 2004, Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease, J Biol Chem, 30, 32345, 10.1074/jbc.M313478200

Byrne, 2012, Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management, Diabet Med, 29, 1098, 10.1111/j.1464-5491.2012.03732.x

Mehal, 2013, The Gordian Knot of dysbiosis, obesity and NAFLD, Nat Rev Gastroenterol Hepatol, 10, 637, 10.1038/nrgastro.2013.146

Jornayvaz, 2012, Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance, Cell Metab, 15, 574, 10.1016/j.cmet.2012.03.005

Samuel, 2012, Mechanisms for insulin resistance: common threads and missing links, Cell, 148, 852, 10.1016/j.cell.2012.02.017

Yamaguchi, 2007, Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis, Hepatology, 45, 1366, 10.1002/hep.21655

Schenk, 2008, Insulin sensitivity: modulation by nutrients and inflammation, J Clin Invest, 118, 2992, 10.1172/JCI34260

Leroux, 2012, Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis, J Hepatol, 57, 141, 10.1016/j.jhep.2012.02.028

Perry, 2014, The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes, Nature, 510, 84, 10.1038/nature13478

Watt, 2012, Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide, Diabetologia, 55, 2741, 10.1007/s00125-012-2649-3

Yang, 2009, Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome, Am J Physiol Endocrinol Metab, 297, E211, 10.1152/ajpendo.91014.2008

Kolesnick, 1998, Regulation of ceramide production and apoptosis, Annu Rev Physiol, 60, 643, 10.1146/annurev.physiol.60.1.643

Lipina, 2011, Sphingolipids: agents provocateurs in the pathogenesis of insulin resistance, Diabetologia, 1, 1596, 10.1007/s00125-011-2127-3

Cantley, 2013, CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance, Proc Natl Acad Sci U S A, 110, 1869, 10.1073/pnas.1219456110

Hotamisligil, 2010, Endoplasmic reticulum stress and the inflammatory basis of metabolic disease, Cell, 140, 900, 10.1016/j.cell.2010.02.034

Tilg, 2008, Insulin resistance, inflammation, and non-alcoholic fatty liver disease, Trends Endocrinol Metab, 19, 371, 10.1016/j.tem.2008.08.005

Targher, 2013, Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications, J Clin Endocrinol Metab, 98, 483, 10.1210/jc.2012-3093

Ix, 2010, Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK, J Am Soc Nephrol, 21, 406, 10.1681/ASN.2009080820

Targher, 2010, Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease, N Engl J Med, 363, 1341, 10.1056/NEJMra0912063

Bhatia, 2012, Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?, Eur Heart J, 33, 1190, 10.1093/eurheartj/ehr453

Oni, 2013, A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?, Atherosclerosis, 230, 258, 10.1016/j.atherosclerosis.2013.07.052

Moon, 2014, Association between nonalcoholic fatty liver disease and carotid artery inflammation evaluated by 18F-fluorodeoxyglucose positron emission tomography, Angiology

Ballestri, 2014, Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease, World J Gastroenterol, 20, 1724, 10.3748/wjg.v20.i7.1724

Stepanova, 2012, Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population, Clin Gastroenterol Hepatol, 10, 646, 10.1016/j.cgh.2011.12.039

Targher, 2007, Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients, Diabetes Care, 30, 1212, 10.2337/dc06-2247

Wong, 2011, Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease, Gut, 60, 1721, 10.1136/gut.2011.242016

Mirbagheri, 2007, Liver: an alarm for the heart?, Liver Int, 27, 891, 10.1111/j.1478-3231.2007.01531.x

Arslan, 2007, Association between nonalcoholic fatty liver disease and coronary artery disease, Coron Artery Dis, 18, 433, 10.1097/MCA.0b013e3282583c0d

Zhou, 2012, Natural course of nonalcoholic fatty liver disease in southern China: a prospective cohort study, J Dig Dis, 13, 153, 10.1111/j.1751-2980.2011.00571.x

Treeprasertsuk, 2012, The Framingham risk score and heart disease in nonalcoholic fatty liver disease, Liver Int, 32, 945, 10.1111/j.1478-3231.2011.02753.x

Targher, 2007, Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients, Diabetes Care, 30, 2119, 10.2337/dc07-0349

Soderberg, 2010, Decreased survival of subjects with elevated liver function tests during a 28-year follow-up, Hepatology, 51, 595, 10.1002/hep.23314

Rafiq, 2009, Long-term follow-up of patients with nonalcoholic fatty liver, Clin Gastroenterol Hepatol, 7, 234, 10.1016/j.cgh.2008.11.005

Matteoni, 1999, Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity, Gastroenterology, 116, 1413, 10.1016/S0016-5085(99)70506-8

Lazo, 2011, Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study, BMJ, 343, d6891, 10.1136/bmj.d6891

Kim, 2013, Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States, Hepatology, 57, 1357, 10.1002/hep.26156

Jepsen, 2003, Prognosis of patients with a diagnosis of fatty liver–a registry-based cohort study, Hepatogastroenterology, 50, 2101

Haring, 2009, Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels, Hepatology, 50, 1403, 10.1002/hep.23135

Hamaguchi, 2007, Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease, World J Gastroenterol, 13, 1579, 10.3748/wjg.v13.i10.1579

Dunn, 2013, Hepatic steatosis in diabetic patients does not predict adverse liver-related or cardiovascular outcomes, Liver Int, 33, 1575, 10.1111/liv.12285

Dam-Larsen, 2004, Long term prognosis of fatty liver: risk of chronic liver disease and death, Gut, 53, 750, 10.1136/gut.2003.019984

Adams, 2005, The natural history of nonalcoholic fatty liver disease: a population-based cohort study, Gastroenterology, 129, 113, 10.1053/j.gastro.2005.04.014

Perseghin, 2008, Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver, Hepatology, 47, 51, 10.1002/hep.21983

Lautamaki, 2006, Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes, Am J Physiol Endocrinol Metab, 291, E282, 10.1152/ajpendo.00604.2005

Rijzewijk, 2010, Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes, J Am Coll Cardiol, 56, 225, 10.1016/j.jacc.2010.02.049

Rijzewijk, 2008, Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus, J Am Coll Cardiol, 52, 1793, 10.1016/j.jacc.2008.07.062

Hallsworth, 2013, Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease, J Hepatol, 58, 757, 10.1016/j.jhep.2012.11.015

Bonapace, 2012, Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes, Diabetes Care, 35, 389, 10.2337/dc11-1820

Kim, 2014, Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population, Heart, 100, 938, 10.1136/heartjnl-2013-305099

Alp, 2013, Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents, Can J Cardiol, 29, 1118, 10.1016/j.cjca.2012.07.846

Singh, 2013, Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease, J Pediatr, 162, 1160, 10.1016/j.jpeds.2012.11.024

Sert, 2013, Left ventricular function by echocardiography, tissue Doppler imaging, and carotid intima-media thickness in obese adolescents with nonalcoholic fatty liver disease, Am J Cardiol, 112, 436, 10.1016/j.amjcard.2013.03.056

Fintini, 2014, Early left ventricular abnormality/dysfunction in obese children affected by NAFLD, Nutr Metab Cardiovasc Dis, 24, 72, 10.1016/j.numecd.2013.06.005

Pacifico, 2014, Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease, Hepatology, 59, 461, 10.1002/hep.26610

Dhingra, 2010, Serum gamma-glutamyl transferase and risk of heart failure in the community, Arterioscler Thromb Vasc Biol, 30, 1855, 10.1161/ATVBAHA.110.207340

Wannamethee, 2012, Gamma-glutamyltransferase, hepatic enzymes, and risk of incident heart failure in older men, Arterioscler Thromb Vasc Biol, 32, 830, 10.1161/ATVBAHA.111.240457

Sinner, 2013, Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation, Am J Cardiol, 111, 219, 10.1016/j.amjcard.2012.09.021

Alonso, 2014, Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort, Heart, 100, 1151, 10.1136/heartjnl-2014-305756

Targher, 2013, Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes, Clin Sci (Lond), 125, 301, 10.1042/CS20130036

Targher, 2013, Non-alcoholic Fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes, PLoS One, 8, e57183, 10.1371/journal.pone.0057183

Targher, 2014, Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes, Nutr Metab Cardiovasc Dis, 24, 663, 10.1016/j.numecd.2014.01.005

Algra, 1991, QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest, Circulation, 83, 1888, 10.1161/01.CIR.83.6.1888

Robbins, 2003, The association between the length of the QT interval and mortality in the Cardiovascular Health Study, Am J Med, 115, 689, 10.1016/j.amjmed.2003.07.014

Newton, 2009, Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease, Clin Auton Res, 19, 319, 10.1007/s10286-009-0031-4

Otto, 2014, Aortic-valve stenosis–from patients at risk to severe valve obstruction, N Engl J Med, 371, 744, 10.1056/NEJMra1313875

Rossi, 2012, Aortic and mitral annular calcifications are predictive of all-cause and cardiovascular mortality in patients with type 2 diabetes, Diabetes Care, 35, 1781, 10.2337/dc12-0134

Markus, 2013, Hepatic steatosis is associated with aortic valve sclerosis in the general population: the Study of Health in Pomerania (SHIP), Arterioscler Thromb Vasc Biol, 33, 1690, 10.1161/ATVBAHA.112.300556

Bonapace, 2014, Nonalcoholic fatty liver disease is associated with aortic valve sclerosis in patients with type 2 diabetes mellitus, PLoS One, 9, e88371, 10.1371/journal.pone.0088371

Targher, 2011, Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link?, J Hepatol, 54, 1020, 10.1016/j.jhep.2010.11.007

Targher, 2014, CKD and nonalcoholic fatty liver disease, Am J Kidney Dis, 64, 638, 10.1053/j.ajkd.2014.05.019

Targher, 2008, Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients, Diabetologia, 51, 444, 10.1007/s00125-007-0897-4

Targher, 2010, Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients, Diabetologia, 53, 1341, 10.1007/s00125-010-1720-1

Hwang, 2010, Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes, Intern Med J, 40, 437, 10.1111/j.1445-5994.2009.01979.x

Targher, 2012, Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liver, Diabet Med, 29, 220, 10.1111/j.1464-5491.2011.03427.x

Li, 2012, Nonalcoholic fatty liver disease associated with impairment of kidney function in nondiabetes population, Biochem Med (Zagreb), 22, 92, 10.11613/BM.2012.010

Ahn, 2013, Non-alcoholic fatty liver disease and chronic kidney disease in Koreans aged 50years or older, Korean J Fam Med, 34, 199, 10.4082/kjfm.2013.34.3.199

Targher, 2010, Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis, Clin J Am Soc Nephrol, 5, 2166, 10.2215/CJN.05050610

Yilmaz, 2010, Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis, Metabolism, 59, 1327, 10.1016/j.metabol.2009.12.012

Yasui, 2011, Nonalcoholic steatohepatitis and increased risk of chronic kidney disease, Metabolism, 60, 735, 10.1016/j.metabol.2010.07.022

Machado, 2012, Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease, Liver Int, 32, 241, 10.1111/j.1478-3231.2011.02623.x

Targher, 2008, Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease, J Am Soc Nephrol, 19, 1564, 10.1681/ASN.2007101155

Chang, 2008, Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men, Metabolism, 57, 569, 10.1016/j.metabol.2007.11.022

Arase, 2011, The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease, Intern Med, 50, 1081, 10.2169/internalmedicine.50.5043

Targher, 2014, Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes, Diabetes Care, 37, 1729, 10.2337/dc13-2704

Stevens, 2006, Assessing kidney function–measured and estimated glomerular filtration rate, N Engl J Med, 354, 2473, 10.1056/NEJMra054415

Bonora, 2012, Increased risk of cardiovascular disease and chronic kidney disease in NAFLD, Nat Rev Gastroenterol Hepatol, 9, 372, 10.1038/nrgastro.2012.79

Shoelson, 2007, Obesity, inflammation, and insulin resistance, Gastroenterology, 132, 2169, 10.1053/j.gastro.2007.03.059

Stefan, 2013, The role of hepatokines in metabolism, Nat Rev Endocrinol, 9, 144, 10.1038/nrendo.2012.258

Byrne, 2014, Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease, Arterioscler Thromb Vasc Biol, 34, 1155, 10.1161/ATVBAHA.114.303034

Targher, 2013, Diagnosis and management of nonalcoholic Fatty liver disease and its hemostatic/thrombotic and vascular complications, Semin Thromb Hemost, 39, 214, 10.1055/s-0033-1334866

Lonardo, 2014, Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease, Expert Rev Gastroenterol Hepatol, 20, 1